New members of the British Pharmacopoeia Commission
Following a successful appointments campaign, four new members have been appointed to the British Pharmacopoeia Commission with effect from 1 May 2022 for a period of 4 years.
- Dr Edward Bush, Principal Scientist – Chemical Development, AstraZeneca
- Mr Carlo Emanuele Giartosio, Regulatory Coordination & Scientific Support Manager, Merck Serono
- Mr Sean Jones, Former Expert Quality Assessor, MHRA; former Trust Quality Controller, Guy’s and St. Thomas’ NHS Foundation Trust
- Mr James Rickard , Chief Scientific & Regulatory Officer, Biotherapy Services
These appointments were made in accordance with the Cabinet Office Code of Governance for Public Appointments following a review of membership undertaken by the Department of Health and Social Care Public Appointments Unit.